Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Berlin plans six vast COVID-19 vaccination centres handling 4,000 people a day

Thu, 26th Nov 2020 15:32

By Caroline Copley

BERLIN, Nov 26 (Reuters) - Berlin is racing to open six mass
vaccination centres capable of handling up to 4,000 people per
day by mid-December, the project coordinator told Reuters on
Thursday, as the city waits for authorities to approve the first
vaccines.

An empty trade fair hall, two airport terminals, a concert
arena, a velodrome and an ice rink will be turned into six
vaccination centres where it plans to administer up to 900,000
shots against the coronavirus in the first three months.

Albrecht Broemme said plans envisage 3,000 to 4,000 people
per day being ferried through each centre in the same way as
shoppers are guided through IKEA stores in one direction.

"The biggest challenge will be succeeding in getting the
right people at the right time at the right vaccination centre,"
Broemme said on the sidelines of a fire drill at the city's
makeshift COVID-19 hospital in a trade fair hall.

Germany appears to be the furthest ahead of European nations
in its planning for the daunting logistical and administrative
challenge that could be just a few weeks away if the first
vaccines gain approval.

Europe's drug watchdog expects to receive the first
application for conditional marketing approval for a COVID-19
vaccine "in the coming days", it said on Thursday, the latest
step towards making a shot available outside the United States.

Broemme said Berlin is working on the assumption that around
80% of its doses in the first instance will come from Pfizer
/BioNTech with the remaining 20% of the doses
from AstraZeneca.

Health Minister Jens Spahn said Germany has secured around
300 million vaccine doses. Other German states have said
vaccination centres will be ready from mid-December and mobile
teams will inoculate the most vulnerable.

Elsewhere in Europe, preparations appear mixed.

In Spain, the government aims to vaccinate a substantial
part of its population in the first half of 2021 and has opted
to use trucks rather than centres to distribute the shots.

Italy expects to have vaccinated most Italians by next
September and is due to set out detailed plans on Dec. 2. France
has said it could start administering shots as soon as the end
of the year and will unveil its strategy next week.

Britain plans to roll out vaccines using a mixture of
centres and doctors' practices and is aiming to have enough
shots to have some sort of normality after Easter.

In contrast, Hungary and Bulgaria are not expecting to
receive their first shipments until Spring.

Berlin's vaccination centres will be open seven days a week
and on public holidays from 0900 to 1900, Broemme said, with the
aim of completing the first phase within three months. After
that people will get shots at doctors' practices and pharmacies.

Those aged over 75 and healthcare workers are expected to be
first-in-line, the city's health senator said last week.

One challenge will be finding enough staff to operate the
centres, which will need medical professionals, stewards and
security guards. EasyJet has offered some of its
first-aid trained staff, a spokesman said.

Broemme expects each person to spend around one hour in the
centre. People will be monitored for side effects for around 30
minutes after receiving a shot amid strict social-distancing and
hygiene standards.
(Reporting by Caroline Copley
Additional reporting by Alistair Smout and Sarah Young in
London, Emilio Paradi in Milan, Emma Pinedo Gonzalez in Madrid,
Matthias Blamont in Paris, Krisztina Than in Budapest, Tsvetelia
Tsolova in Sofia)

More News
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.